Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vitamin D analogues for secondary prevention of type 1 diabetes in children and adolescents
ISRCTN17354692Phase 2Recruiting
- Sponsor
- Pediatric Endocrine Clinics
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, open-label trial of calcitriol, paricalcitol, MART-10 and vitamin d in diabetes mellitus type 1 (T1D), prediabetes, celiac disease and 1 more (3 arms), sponsored by Pediatric Endocrine Clinics. Primary endpoints: Type 1 diabetes-associated autoantibodies, Glucose metabolism and 1 more. Started Jun 2010; status: recruiting.
02
Drugs
calcitriolparicalcitolMART-10vitamin d
03
Conditions
diabetes mellitus type 1 (T1D)prediabetesceliac diseaseautoimmune thyroid disease (AITD)
Beyond the preview
Go deeper on ISRCTN17354692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17354692.